PET/CT

Photo

PET-CT vs. whole-body MRI

For many indications, because PET-CT produces a very high accuracy for many tumours, this modality is the gold standard, Prof. Reiser confirmed. It also enables good observation of the course of the disease. After an injection of radioactive tracers we can visualise increased metabolic activity in great detail and with high sensitivity. This is an increasingly important issue not only in primary…

Expanding your diagnostic imaging services?

If you need to expand your diagnostic imaging services and a fixed installation is too costly but a mobile solution cannot cover your demand, Alliance Medical, Europe's largest provider of out-sourced diagnostic imaging services, reports that it could become your partner. "Did you ever think about a semi-static installation?" the company asks. "The services we can offer by far exceed the…

Imaging Crucial for personalized medicine

'Personalized medicine' -- where therapy is designed for the individual patient -- is a popular concept in healthcare today, but according to a new market research report, it will be driven by the imaging industry, especially the new molecular technologies. If images can reveal not just the heightened metabolic activity characteristic of tumors but the tumors' chemical signatures, physicians can…

Molekulare Bildgebung von Karzinomen

Chirurgen an der Charité haben in kolorektalem Tumorgewebe eine spezifische Anhäufung von Protoporphyrin-IX (PpIX), einem rot-fluoreszierenden Vorläufermolekül des Häms beobachtet. Wir konnten zeigen, dass diese Anhäufung von PpIX darauf zurückzuführen ist, dass das Enzym, das PpIX normalerweise in Häm überführt, die sogenannte…

Photo

Siemens Biograph mCT PET/CT

Siemens Healthcare reported at the annual meeting of the European Association of Nuclear medicine (EANM) in Barcelona, Spain, that leading hospitals in England, France, Germany and Monaco have shown strong interest and adoption of the Biograph mCT, the worlds first molecular CT, to fuel advanced diagnostic capabilities and to drive greater workflow efficiencies.

Berlin's treatment centres

Founded and managed by Prof Peter Schlag, the Charité Comprehensive Cancer Centre (CCCC) co-ordinates cancer diagnostics and therapies across all medical disciplines. Interdisciplinary tumour boards decide on therapies/strategies; cooperation is close with general practitioners, regional hospitals and clinics.

Photo

Bayer presents positive Phase II data with florbetaben

Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the novel positron emission tomography (PET) tracer florbetaben (BAY 94-9172) at the International Conference on Alzheimer's Disease (ICAD) in Vienna, Austria. This study showed that patients with a clinical diagnosis of Alzheimer´s disease could be differentiated from age-matched healthy volunteers…

Alzheimer disease: positive Phase II data with florbetaben

Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the novel positron emission tomography (PET) tracer florbetaben (BAY94-9172) at the International Conference on Alzheimer's Disease (ICAD) in Vienna, Austria. This study showed that patients with a clinical diagnosis of Alzheimer´s disease could be differentiated from age-matched healthy volunteers…

Photo

The 90th German Radiology Congress

"Radiologists often see cancer patients over a period of years and continuously deliver important information for the treatment process," says Claus D. Claussen MD, Professor of Radiology and Director of the Clinic for Diagnostic and Interventional Radiology at the University Hospital in Tübingen and President of the 90th German Radiology Congress. For the first time in the history of this…

Photo

GE's new Discovery PET/CT 600 scanners go global

GE Healthcare's first Discovery PET/CT 600-series scanners are being installed in a number of leading clinics around the world. "This first set of installations is a big step forward in the diagnosis and monitoring of disease", said Terri Bresenham, newly appointed vice- president and general manager of GE Healthcare's global Molecular Imaging business.

Photo

EAU hot topic: Imaging in urological oncology today

Big discussions are expected at the upcoming European Association of Urology (EAU) Congress in Stockholm* when urologist Dr Jochen Walz (right), of the Urological Department at the Institute Paoli-Calmettes, Marseilles, France, presents the forum: Imaging in Europe: Who, where, what, how many! and M F Coelho, of the European Society of Urological Imaging (ESUI) describes the Clinical utility of…

Photo

Biograph mCT

At Medica 2008, Siemens introduced its latest generation PET-CT, the Biograph mCT. During a European Hospital interview, Markus Lusser (ML), worldwide Head of Distribution and Marketing for Molecular Imaging at Siemens, outlined the advantages of the new hybrid system, which aims to extend the spectrum of medical imaging to 'molecular computed tomography'

Photo

GE Healthcare Launches Discovery PET/CT 600

GE Healthcare showcases its intelligence in PET/CT technology by introducing the latest addition to its PET/CT family, the Discovery PET/CT 600 at the 94th annual Radiological Society of North America annual in Chicago.

Photo

New concepts for dose reduction in the diagnosis of coronary heart disease with CT

Professor Stefan Schönberg of the Institute of Clinical Radiology and Nuclear Medicine (IKRN), University Hospital Mannheim, Medical Faculty of Mannheim, University of Heidelberg, invited colleagues from Mannheim and the Federal Office for Radiation Protection (BFS) in Neuherberg for a round-table discussion on: Non-invasive multidetector coronary CT angiography (CTA) has become an established…

Photo

Will there be a lack of radiopharmaceuticals?

The shortage of radiopharmaceuticals due to the planned shutdown of some nuclear reactors will now be discussed by the European Medicines Agency (EMEA). The European Commission (DG Enterprise and Industry) asked EMEA to analyse the extend and to develop potential approaches to address any problems.

Photo

Research to prolong the retention time in the blood

The University of Urbino and Philips Research will jointly research the encapsulation of magnetic nanoparticle contrast agents inside living blood cells to prolong the retention time of these agents in the blood. Injected as free particles, magnetic nanoparticle contrast agents are quickly excreted from the blood via the patient's liver, which limits their application.

Photo

PET scans save colorectal cancer patients' lives

Colorectal cancer is one of the most common cancers to cause death. A PET scan improves prognosis and changes management of recurrent colorectal cancer in more than half of patients according to a latest study from Australia. Therefore, the data suggest to conduct nuclear imaging in cancer treatment more often.

Photo

Seasonal mood changes visualised by PET

Seasons change - and so does our mood. When days become shorter and hours of sunlight become fewer some of us suffer from seasonal depression. Brain scans taken at different times of the year brings it to light: sun makes happy.…

42 show more articles
Subscribe to Newsletter